Autism Spectrum Disorder Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People with an estimated full-scale IQ above 80
- People who are right-handed
- People who are fluent in English
- People who are able to cooperate with all of the study's procedures
- People with no history of neurological conditions (such as epilepsy) or brain surgery
- People with no major medical conditions (such as cancer or heart failure)
- People with no history of significant head injury
- People with no close biological relatives who have a neurological condition that may be inherited, including epilepsy or multiple sclerosis (MS)
- People who are not currently taking medications that affect mood, thinking, or brain activity (such as benzodiazepines, anti-seizure, or pro-convulsant medications)
- People who are not currently using substances, as confirmed by a urine screen and breathalyzer test at each visit
- Women who have a negative pregnancy test at the time of MRI scans
- People with no reasons that would make an MRI scan unsafe for them (such as metal implants inside the body or severe claustrophobia)
- People who have not previously taken part in a study in this lab that included a specific task called the Domino fMRI task
- For people with ASD: Those who have been on a stable medication plan for at least 4 weeks before joining the study
- For people in the control group: Those with no current or past psychiatric conditions (other than simple phobia), and no close biological relatives with ASD
Who may not be able to join:
- No formal exclusion criteria were listed separately in the trial record; the inclusion criteria above describe the full set of requirements (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Vaughn Steele, MD, Yale University
Phone: 860-545-7792
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Mentalizing Task Related (MTR) neural activity in the mentalizing network
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.